The French National Institute of Health and Medical Research, known as Inserm, according to some accounts is the second-leading biomedical research institution worldwide as measured by publications with over 12,000 completed and published annually. With 10,000 researchers investigating everything from public health improvements to novel therapies, the French research powerhouse selected an artificial intelligence-based research tool called Clinical Research Navigator (CRN). Now available for 100 of its researchers, the team will evaluate the research tool for six months.
This news comes by way of the maker of the AI-based research tool called Expert Systems. TrialSite News notes that Inserm didn’t make an outright purchase but rather appears to have settled for a six month pilot. As part of this evaluation, the Inserm researchers will have unlimited access to over 100 million documents and reference information on 12 million clinical studies, including clinical trial data, patents, reports from experts and health organizations, and not to mention web and social network content.
Key Value Proposition
Apparently the differentiating factor for this research tool centers on “...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).